Who are we?

ARREST BLINDNESS is a consortium performing a four-year research project funded by the HORIZON 2020 program of the European Commission. Within the project we are developing and validating advanced regenerative and restorative therapies to treat the loss of corneal transparancy so that it does not result in blindness.

The cornea

The cornea is the most anteriorly located ocular tissue, serving principally as a transparent window for light to enter the human eye. Besides the function of transparency, the curved cornea serves to refract light to deeper ocular structures, and presents a biological barrier to the outer environment.

News

Upcoming event: symposium showcasing the results of ARREST BLINDNESS

A special interest symposium showcasing the results of ARREST... Read more

Second Reporting Period completed

A cornerstone of ARREST BLINDNESS is four clinical studies, each... Read more

This project has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under Grant Agreement No. 667400-2.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.